Literature DB >> 30089811

Increased risk of skin cancer in Japanese heterozygotes of xeroderma pigmentosum group A.

Yuko Hirai1, Asao Noda2, Yoshiaki Kodama2, Kismet A Cordova3, Harry M Cullings3, Shuji Yonehara4, Megumu Fujihara5, Shin-Ichi Moriwaki6, Chikako Nishigori7, Kiyohiko Mabuchi8, Kenneth H Kraemer9, Nori Nakamura2.   

Abstract

This study was designed to learn if asymptomatic heterozygotes with mutations in a DNA repair gene are at an increased risk for cancer. To examine this, we focused on carriers of an XPA founder mutation because the frequency of xeroderma pigmentosum (XP) patients is much greater among Japanese than Caucasians, more than half of Japanese XP patients are affected at the XPA gene, and the majority of XP-A patients carry the same founder mutation in the XPA gene. Here we show that the frequency of XPA heterozygote was 14/1698 (0.8%) in cancer-free controls, and the corresponding frequency in patients with nonmelanocytic skin cancer that developed in sun-exposed areas was 11/440 (2.5%, OR = 3.08, p = 0.0097) for basal cell carcinoma, and 3/272 (1.1%, OR = 1.34, p = 0.72) for squamous cell carcinoma. These results suggest a moderately elevated risk for skin cancer among XPA heterozygotes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30089811      PMCID: PMC8057111          DOI: 10.1038/s10038-018-0495-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

Review 1.  Xeroderma pigmentosum--bridging a gap between clinic and laboratory.

Authors:  S Moriwaki; K H Kraemer
Journal:  Photodermatol Photoimmunol Photomed       Date:  2001-04       Impact factor: 3.135

2.  Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.

Authors:  Yuko Hirai; Yoshiaki Kodama; Shin-Ichi Moriwaki; Asao Noda; Harry M Cullings; Donald G Macphee; Kazunori Kodama; Kiyohiko Mabuchi; Kenneth H Kraemer; Charles E Land; Nori Nakamura
Journal:  Mutat Res       Date:  2006-08-14       Impact factor: 2.433

3.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 4.  Heterozygous manifestations in four autosomal recessive human cancer-prone syndromes: ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia, and Bloom syndrome.

Authors:  R A Heim; N J Lench; M Swift
Journal:  Mutat Res       Date:  1992-12-01       Impact factor: 2.433

5.  An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study.

Authors:  H Shen; E M Sturgis; S G Khan; Y Qiao; T Shahlavi; S A Eicher; Y Xu; X Wang; S S Strom; M R Spitz; K H Kraemer; Q Wei
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 6.  Genetics and skin cancer of xeroderma pigmentosum in Japan.

Authors:  H Takebe; C Nishigori; Y Satoh
Journal:  Jpn J Cancer Res       Date:  1987-11

7.  Histologic characteristics of skin cancer in Hiroshima and Nagasaki: background incidence and radiation effects.

Authors:  Masao Kishikawa; Kojiro Koyama; Masachika Iseki; Toshihiro Kobuke; Shuji Yonehara; Midori Soda; Elaine Ron; Masayoshi Tokunaga; Dale L Preston; Kiyohiko Mabuchi; Shoji Tokuoka
Journal:  Int J Cancer       Date:  2005-11-10       Impact factor: 7.396

8.  Characterization of a splicing mutation in group A xeroderma pigmentosum.

Authors:  I Satokata; K Tanaka; N Miura; I Miyamoto; Y Satoh; S Kondo; Y Okada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 9.  Shining a light on xeroderma pigmentosum.

Authors:  John J DiGiovanna; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.